HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Supplements For Disease-Related Nutrition Shaping Consumer Health Landscape

This article was originally published in The Rose Sheet

Executive Summary

Sales of dietary supplements promoted for nutritional needs of diabetics are exploding as consumers seek non-drug products to deal with symptoms of the disease, says a consumer health analyst in a recent presentation. Consumer health products positioned to prevent disease are growing at a much faster rate globally than those formulas that treat ailments.

You may also be interested in...



Health, Beauty And Wellness News: FTC, ADM, Hain, CRN, Boston Therapeutics

AuraVie 'risk free' marketer enforcement closes; ADM makes second proibiotics move; Hain Celestial announces CEO succession plan; CRN updates guidelines on SARMs, caffeine; and Sugardown supplement added to Kathy Ireland band.

IoniCell, BiomeBliss, Coromega, Ashwagandha: Health And Wellness New Products

Ionicell for Women with Ioniplex; BiomeBliss nourishes, protects GI biome; Coromega packs MCTs in Max; and Physicians' Choice capsules have 1,950 mg ashwagandha.

Young Health Catalogs Drug Claims: Health And Wellness Industry News

Young Health catalogs its drug claims; Evolve Brands absorbs Gorilly Goods and Supernola; Libby is Herbalife CIO; and AHPA 'Botanical Safety Handbook' available

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121700

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel